Moreover, fusokines such as the FIST protein, consisting of interleukin-2 (IL-2) and the ectodomain of the TGF-β receptor II, have been developed to combine immune activation and tumor modulation [7, 8]. The gene discussed is IL2; the disease is neoplasm.